Resources
About Us
Home Report
Store
Clinical Trial Supplies Market
Clinical Trial Supplies Market by Phase (I–IV) Service (Manufacturing, Packaging, Logistic, Documentation) Type (Biologic, Small-molecule, Medical Device) Therapy Area (Oncology, Cardiology, CNS, Immunology, Respiratory) End User - Global Forecast to 2031
Report ID:MRHC - 104373 Pages: 260 Feb-2024 Formats*: PDF Category: Healthcare Delivery: 24 to 48 HoursThe Clinical Trial Supplies Market was valued at $3.11 billion in 2023. This market is expected to reach $5.59 billion by 2031, from an estimated $3.33 billion in 2024, at a CAGR of 7.7% during the forecast period 2024-2031.
Clinical Trial Supplies Market Size & Forecast
Clinical trial supplies are products and services required during clinical trials, including expertise/assistance, 24-hour collection and delivery of biological specimens (including infectious samples), investigational drugs, kits, and study materials. Clinical trial supplies must be properly maintained and managed to comply with regulatory guidelines and meet quality standards. Clinical trial supplies are transported, stored, and tracked according to regulatory requirements. Clinical trial supply services include logistic, shipping, and distribution services, inventory management services, temperature monitoring, labeling, and primary and secondary packaging.
The growth of this market is mainly driven by the rising number of clinical trials, the increasing decentralization of clinical trials, increasing approvals for generic drugs & biopharmaceuticals, increasing R&D expenditures among pharmaceutical & biopharmaceutical companies, and the rising need for novel therapies. However, the high costs of drug development restrain the growth of this market.
Furthermore, emerging economies and drug patent expirations are generating market growth opportunities. However, changes in the regulatory landscape and clinical trial failures in cases of rare diseases are major challenges impacting market growth.
Increasing Number of Clinical Trials Driving Market Growth
Pharmaceutical companies constantly focus on Research and Development (R&D), which are the core of drug development processes. The biotechnology industry also continues to witness substantial growth due to increased investments in R&D to cater to the growing demand for innovation and new medical breakthroughs. According to the National Investment Promotion and Facilitation Agency (India), in 2022, India invested $1 billion in biotechnology R&D. In September 2022, the U.S. government announced federal funding of $2 billion to support the biotechnology and biomanufacturing sector. Growing R&D spending has increased the focus on efficient clinical trials management. Additionally, the number of drug approvals is gradually increasing, boosting the adoption of clinical trial supply services for efficient management of clinical trials. For instance, in 2023, the Center for Drug Evaluation and Research (CDER) approved 55 novel drugs, increasing from 37 drugs in 2022. Thus, high R&D investments in the life sciences sector are expected to drive the adoption of clinical trial supplies.
Most companies and CROs are using clinical trial supply services to allow researchers to manage all activities related to the setup, conduction, and closeout of clinical trials. These services facilitate planning, preparation, monitoring, tracking, reporting, and compliance.
Additionally, with the increasing number of clinical trials, pharmaceutical companies are focusing more on drug pipelines such as antiviral drugs, orphan drugs, and immune-oncology drugs. As the number of drugs in the pipeline is increasing, the number of clinical trials is also increasing, supporting the growth of the clinical trial supplies market. According to ClinicalTrials.gov, the number of clinical trials increased to 477,237 in 2023 from 399,484 in 2021.
Rising Adoption of Generic Drugs & Biopharmaceuticals Driving the Demand for Clinical Trial Supplies
The preference for biopharmaceuticals is rising due to their ability to target specific molecules, lower side effects, and high activity and specificity. Biopharmaceuticals are increasingly being used for treating Immune-mediated Inflammatory Diseases (IMIDs), including rheumatic diseases, such as Rheumatoid Arthritis (RA), Inflammatory Bowel Disease (IBD), and cancer. The demand for generic drugs is also increasing as they are available at lower costs and help save on drug expenditure. According to the U.S. FDA, 91% of all prescriptions in the U.S. recommend generic drugs, with more than 32,000 generic drugs approved by the FDA as of 2022.
Clinical trial supplies are essential in the biopharmaceuticals sector to ensure standardized and high-quality products. Biopharmaceutical firms can ensure constant adherence to quality standards, compliance with regulations, and continual improvements in organizational processes by using clinical trial supplies.
Click here to: Get Free Sample Pages of this Report
Key Findings in the Global Clinical Trial Supplies Market Study:
The Phase III Segment Projected to Register the Highest CAGR During the Forecast Period
Based on clinical phase, the clinical trial supplies market is segmented into phase I, phase II, phase III, and phase IV. The phase III segment is expected to register the highest CAGR during the forecast period. Phase III clinical trials show researchers the rare or long-term side effects of a medication. The demand for clinical trial supplies is the highest in phase III due to the higher complexity of phase III clinical trials compared to other phases. The complexity of phase III is associated with the recruitment of study participants for randomized clinical trials. According to Allucent (U.S.), a provider of drug development solutions, every year, about 30% of drugs in phase III fail to reach approval. Owing to the high failure rate of phase III clinical trials, the need for the careful management and planning of clinical trial supplies is the highest in phase III.
The Logistics & Distribution Segment Expected to Account for the Largest Market Share in 2024
Based on service, the clinical trial supplies market is segmented into manufacturing, packaging, and labeling, logistics & distribution, documentation, and other services. In 2024, the logistics & distribution segment is expected to account for the largest share of the clinical trial supplies market. The logistic challenges in clinical trials are increasing the demand for logistic & distribution services. Logistic & distribution challenges include drugs getting stalled in cross-border customs in case of global trials, a lack of sufficient ancillary supplies to serve patients, and damage to patient samples during shipping. Additionally, key players are collaborating with market stakeholders to provide integrated solutions for clinical trial supplies. For instance, in January 2023, Cryoport, Inc. (U.S.) collaborated with Syneos Health (U.S.) to integrate clinical trial supply services offered by Syneos Health with IntegriCell, Cryoport’s platform providing standardized apheresis collection, cryopreservation, storage, and distribution for cell & gene therapies.
The Biologics Segment Projected to Register the Highest CAGR During the Forecast Period
Based on type, the clinical trial supplies market is segmented into medical devices, biologics, and small molecules. The biologics segment is expected to register the highest CAGR during the forecast period. The high growth of this segment is driven by the growing demand for biologics, increasing research on the development of biosimilar drugs, and the increasing use of biologics for the treatment of autoimmune diseases. Additionally, increasing approvals for biologics support the segment’s highest CAGR. According to the U.S. FDA, in 2022, 40.5% of biologics were approved, compared to 28% in 2021.
The Oncology Segment Expected to Dominate the Market in 2024
Based on therapeutic area, the clinical trial supplies market is segmented into cardiology, infectious diseases, oncology, CNS, inflammation & immunology, metabolic disorders, respiratory disorders, and other therapeutic areas. In 2024, the oncology segment is expected to account for the largest share of the market. The segment’s large share is attributed to the increasing incidence of cancer, the rising focus on developing novel therapies for the treatment of cancer, and the increasing number of drugs in the R&D pipeline for cancer treatment. Additionally, the increasing percentage of oncology drugs in clinical trials supports the segment’s large market share. For instance, in the third quarter of 2023, the U.S. FDA and the European Medicines Agency (EMA) collectively approved over 36 oncology drugs compared to 30 in the third quarter of 2022.
The Pharmaceutical & Biotechnology Companies Segment Expected to Account for the Largest Market Share in 2024
Based on end user, the clinical trial supplies market is segmented into pharmaceutical & biotechnology companies, contract research organizations, medical device manufacturers, and clinical research organizations. In 2024, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of the market. The segment’s large market share is attributed to significant investments in research and development (R&D) and infrastructure development by pharmaceutical & biotechnology companies. The funding for research laboratories is increasing due to the rising demand for new drugs and therapies. For instance, according to the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), global pharmaceutical R&D expenditure is expected to reach $213 billion in 2026 from $179 billion in 2020.
North America to be the Largest Regional Market
In 2024, North America is expected to account for the largest share of the clinical trial supplies market. North America's significant market share is attributed to several factors, including substantial R&D investments by pharmaceutical and biotechnology companies for drug and biomarker development, the growing prevalence of chronic diseases, increased healthcare expenditures, the presence of key market players in the region, and favorable government initiatives supporting research and development. The surge in R&D spending by pharmaceutical companies is anticipated to drive the demand for clinical trial supplies, which are crucial for successful clinical trials in the pharmaceutical sector. For instance, in 2022, overall pharmaceutical expenditures in the U.S. grew by 9.4% compared to 2021.
Clinical Trial Supplies Market: Competitive Analysis
The report offers a competitive landscape based on an extensive assessment of the product offerings and geographic presence of leading market players and the key growth strategies adopted by them over the past few years (2020–2024). The key players operating in the clinical trial supplies market are Catalent, Inc. (U.S.), NUVISAN GmbH (Germany), Thermo Fisher Scientific Inc. (U.S.), Almac Group (U.K.), Eurofins Scientific SE (Luxembourg), Parexel International (MA) Corporation (U.S.), Marken (U.S.), Biocair International Limited (U.K.), KLIFO (Denmark), Piramal Pharma Limited (India), Movianto Group (U.K.), and ICON plc (Ireland).
Clinical Trial Supplies Market Report Summary:
|
Particulars |
Details |
|
Number of Pages |
~260 |
|
Format |
|
|
Forecast Period |
2024-2031 |
|
Base Year |
2023 |
|
CAGR |
7.7% |
|
Estimated Market Size (Value) |
$5.59 Billion by 2031 |
|
Segments Covered |
By Clinical Phase
By Service
By Type
By Therapeutic Area
By End User
|
|
Regions/Countries Covered |
North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, RoE), Asia-Pacific (China, Japan, India, RoAPAC), Latin America (Brazil, Mexico, RoLATAM), and the Middle East & Africa |
|
Key Companies Profiled |
Catalent, Inc. (U.S.), NUVISAN GmbH (Germany), Thermo Fisher Scientific Inc. (U.S.), Almac Group (U.K.), Eurofins Scientific SE (Luxembourg), Parexel International (MA) Corporation (U.S.), Marken (U.S.), Biocair International Limited (U.K.), KLIFO (Denmark), Piramal Pharma Limited (India), Movianto Group (U.K.), and ICON plc (Ireland) |
Key questions answered in the report:
The clinical trial supplies market report covers the study of market segments by service, clinical phase, type, therapeutic area, and end user. This report also analyzes the clinical trial supplies market at the regional and country levels.
The clinical trial supplies market is projected to reach $5.59 billion by 2031 at a CAGR of 7.7% during the forecast period.
The biologics segment is expected to register the highest CAGR during the forecast period. The high growth of this segment is driven by the increasing approvals for biologics, pharmaceutical companies’ increasing focus on developing biologics, and the growing focus on specialty medicine.
In 2024, the oncology segment is expected to account for the largest share of the clinical trial supplies market. The large market share of this segment is attributed to the increasing R&D expenditures by pharmaceutical companies on oncology drug development, the rising focus on personalized medicine, and the high failure rates of oncology drug clinical trials.
The growth of this market is driven by the rising number of clinical trials, the increasing decentralization of clinical trials, the proliferation of biologics & biosimilar drugs, growing R&D expenditures of pharmaceutical & biopharmaceutical companies, and the increasing need for novel therapies. However, the high costs of drug development restrain the market’s growth.
Furthermore, emerging economies and drug patent expirations are generating growth opportunities for the players in this market. However, the changing regulatory landscape and clinical trial failures in cases of rare diseases are major challenges impacting the market’s growth.
The key players operating in the clinical trial supplies market are Catalent, Inc. (U.S.), NUVISAN GmbH (Germany), Thermo Fisher Scientific Inc. (U.S.), Almac Group (U.K.), Eurofins Scientific SE (Luxembourg), Parexel International (MA) Corporation (U.S.), Marken (U.S.), Biocair International Limited (U.K.), KLIFO (Denmark), Piramal Pharma Limited (India), Movianto Group (U.K.), and ICON plc (Ireland).
The emerging countries in Asia-Pacific are projected to offer significant growth opportunities for the vendors in this market due to the growing healthcare infrastructure, increasing number of research laboratories, and growing availability of research funding in the region.
1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency and Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecasting
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumptions for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Drivers
4.2.1. Rising Number of Clinical Trials
4.2.2. Increasing Decentralization of Clinical Trials
4.2.4. Rise in R&D Expenditure Among Pharmaceutical and Biopharmaceutical Companies
4.2.5. Increasing Need for Novel Therapies
4.3. Restraint
4.3.1. High Costs Associated with Drug Development
4.4. Opportunities
4.4.1. Emerging Economies
4.4.2 Drug Patent Expirations
4.5. Challenges
4.5.1. Changes in Regulatory Landscape
4.5.2. Clinical Trial Failures, Particularly in Cases of Rare Diseases
4.6. Factor Analysis
4.7. Trends
4.8. Regulatory Analysis
4.9. Pricing Analysis
4.10. Porter’s 5 Force Analysis
5. Clinical Trial Supplies Market Assessment—by Clinical Phase
5.1. Overview
5.2. Phase I
5.3. Phase II
5.4. Phase III
5.5. Phase IV
6. Clinical Trial Supplies Market Assessment—by Service
6.1. Overview
6.2. Manufacturing
6.3. Packaging & Labeling
6.4. Logistics & Distribution
6.5. Documentation
6.6. Other Services
7. Clinical Trial Supplies Market Assessment—by Type
7.1. Overview
7.2. Medical Devices
7.3. Biologics
7.4. Small Molecules
8. Clinical Trial Supplies Market Assessment—by Therapeutic Area
8.1. Overview
8.2. Cardiology
8.3. Infectious Diseases
8.4. Oncology
8.5. CNS
8.6. Inflammation & Immunology
8.7. Metabolic Disorders
8.8. Respiratory Disorders
8.9. Other Therapeutic Areas
9. Clinical Trial Supplies Market Assessment—by End User
9.1. Overview
9.2. Pharmaceutical & Biotechnology Companies
9.3. Contract Research Organizations
9.4. Medical Device Manufacturers
9.5. Clinical Research Organizations
10. Clinical Trial Supplies Market Assessment—by Geography
10.1. Overview
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. U.K.
10.3.4. Italy
10.3.5. Spain
10.3.6. Rest of Europe (RoE)
10.4. Asia-Pacific
10.4.1. Japan
10.4.2. China
10.4.3. India
10.4.4. Rest of Asia-Pacific (RoAPAC)
10.5. Latin America
10.5.1. Brazil
10.5.2. Mexico
10.5.3. Rest of Latin America (RoLATAM)
10.6. Middle East & Africa
11. Competition Analysis
11.1. Overview
11.2. Key Growth Strategies
11.3. Competitive Benchmarking
11.4. Competitive Dashboard
11.4.1. Industry Leaders
11.4.2. Market Differentiators
11.4.3. Vanguards
11.4.4. Emerging Companies
11.5. Market Share Analysis/Market Ranking, by Key Players (2023)
12. Company Profiles (Company Overview, Financial Snapshot, Product Portfolio, Strategic Developments, and SWOT Analysis)
12.1. Catalent, Inc.
12.2. NUVISAN GmbH
12.3. Thermo Fisher Scientific Inc.
12.4. Almac Group
12.5. Eurofins Scientific SE
12.6. Parexel International (MA) Corporation
12.7. Marken
12.8. Biocair International Limited
12.9. KLIFO
12.10. Piramal Pharma Limited
12.11. Movianto Group
12.12. ICON plc
(Note: SWOT Analysis Will be Provided for the Top 5 companies)
13. Appendix
13.1. Available Customization
13.2. Related Reports
List of Tables
Table 1 Global Clinical Trial Supplies Market, by Clinical Phase, 2022–2031 (USD Million)
Table 2 Global Clinical Trial Supplies Market for Phase I, by Country/Region, 2022–2031 (USD Million)
Table 3 Global Clinical Trial Supplies Market for Phase II, by Country/Region, 2022–2031 (USD Million)
Table 4 Global Clinical Trial Supplies Market for Phase III, by Country/Region, 2022–2031 (USD Million)
Table 5 Global Clinical Trial Supplies Market for Phase IV, by Country/Region, 2022–2031 (USD Million)
Table 6 Global Clinical Trial Supplies Market, by Service, 2022–2031 (USD Million)
Table 7 Global Clinical Trial Supplies Market for Manufacturing, by Country/Region, 2022–2031 (USD Million)
Table 8 Global Clinical Trial Supplies Market for Packaging & Labeling, by Country/Region, 2022–2031 (USD Million)
Table 9 Global Clinical Trial Supplies Market for Logistics & Distribution, by Country/Region, 2022–2031 (USD Million)
Table 10 Global Clinical Trial Supplies Market for Documentation, by Country/Region, 2022–2031 (USD Million)
Table 11 Global Clinical Trial Supplies Market for Other Services, by Country/Region, 2022–2031 (USD Million)
Table 12 Global Clinical Trial Supplies Market, by Type, 2022–2031 (USD Million)
Table 13 Global Clinical Trial Supplies Market for Medical Devices, by Country/Region, 2022–2031 (USD Million)
Table 14 Global Clinical Trial Supplies Market for Biologics, by Country/Region, 2022–2031 (USD Million)
Table 15 Global Clinical Trial Supplies Market for Small Molecules, by Country/Region, 2022–2031 (USD Million)
Table 16 Global Clinical Trial Supplies Market, by Therapeutic Area, 2022–2031 (USD Million)
Table 17 Global Clinical Trial Supplies Market for Cardiology, by Country/Region, 2022–2031 (USD Million)
Table 18 Global Clinical Trial Supplies Market for Infectious Diseases, by Country/Region, 2022–2031 (USD Million)
Table 19 Global Clinical Trial Supplies Market for Oncology, by Country/Region, 2022–2031 (USD Million)
Table 20 Global Clinical Trial Supplies Market for CNS, by Country/Region, 2022–2031 (USD Million)
Table 21 Global Clinical Trial Supplies Market for Inflammation & Immunology, by Country/Region, 2022–2031 (USD Million)
Table 22 Global Clinical Trial Supplies Market for Metabolic Disorders, by Country/Region, 2022–2031 (USD Million)
Table 23 Global Clinical Trial Supplies Market for Respiratory Disorders, by Country/Region, 2022–2031 (USD Million)
Table 24 Global Clinical Trial Supplies Market for Other Therapeutic Areas, by Country/Region, 2022–2031 (USD Million)
Table 25 Global Clinical Trial Supplies Market, by End User, 2022–2031 (USD Million)
Table 26 Global Clinical Trial Supplies Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2022–2031 (USD Million)
Table 27 Global Clinical Trial Supplies Market for Contract Research Organizations, by Country/Region, 2022–2031 (USD Million)
Table 28 Global Clinical Trial Supplies Market for Medical Device Manufacturers, by Country/Region, 2022–2031 (USD Million)
Table 29 Global Clinical Trial Supplies Market for Clinical Research Organizations, by Country/Region, 2022–2031 (USD Million)
Table 30 Global Clinical Trial Supplies Market, by Region, 2022–2031 (USD Million)
Table 31 North America: Clinical Trial Supplies Market, by Country, 2022–2031 (USD Million)
Table 32 North America: Clinical Trial Supplies Market, by Clinical Phase, 2022–2031 (USD Million)
Table 33 North America: Clinical Trial Supplies Market, by Service, 2022–2031 (USD Million)
Table 34 North America: Clinical Trial Supplies Market, by Type, 2022–2031 (USD Million)
Table 35 North America: Clinical Trial Supplies Market, by Therapeutic Area, 2022–2031 (USD Million)
Table 36 North America: Clinical Trial Supplies Market, by End User, 2022–2031 (USD Million)
Table 37 U.S.: Clinical Trial Supplies Market, by Clinical Phase, 2022–2031 (USD Million)
Table 38 U.S.: Clinical Trial Supplies Market, by Service, 2022–2031 (USD Million)
Table 39 U.S.: Clinical Trial Supplies Market, by Type, 2022–2031 (USD Million)
Table 40 U.S.: Clinical Trial Supplies Market, by Therapeutic Area, 2022–2031 (USD Million)
Table 41 U.S.: Clinical Trial Supplies Market, by End User, 2022–2031 (USD Million)
Table 42 Canada: Clinical Trial Supplies Market, by Clinical Phase, 2022–2031 (USD Million)
Table 43 Canada: Clinical Trial Supplies Market, by Service, 2022–2031 (USD Million)
Table 44 Canada: Clinical Trial Supplies Market, by Type, 2022–2031 (USD Million)
Table 45 Canada: Clinical Trial Supplies Market, by Therapeutic Area, 2022–2031 (USD Million)
Table 46 Canada: Clinical Trial Supplies Market, by End User, 2022–2031 (USD Million)
Table 47 Europe: Clinical Trial Supplies Market, by Country/Region, 2022–2031 (USD Million)
Table 48 Europe: Clinical Trial Supplies Market, by Clinical Phase, 2022–2031 (USD Million)
Table 49 Europe: Clinical Trial Supplies Market, by Service, 2022–2031 (USD Million)
Table 50 Europe: Clinical Trial Supplies Market, by Type, 2022–2031 (USD Million)
Table 51 Europe: Clinical Trial Supplies Market, by Therapeutic Area, 2022–2031 (USD Million)
Table 52 Europe: Clinical Trial Supplies Market, by End User, 2022–2031 (USD Million)
Table 53 Germany: Clinical Trial Supplies Market, by Clinical Phase, 2022–2031 (USD Million)
Table 54 Germany: Clinical Trial Supplies Market, by Service, 2022–2031 (USD Million)
Table 55 Germany: Clinical Trial Supplies Market, by Type, 2022–2031 (USD Million)
Table 56 Germany: Clinical Trial Supplies Market, by Therapeutic Area, 2022–2031 (USD Million)
Table 57 Germany: Clinical Trial Supplies Market, by End User, 2022–2031 (USD Million)
Table 58 France: Clinical Trial Supplies Market, by Clinical Phase, 2022–2031 (USD Million)
Table 59 France: Clinical Trial Supplies Market, by Service, 2022–2031 (USD Million)
Table 60 France: Clinical Trial Supplies Market, by Type, 2022–2031 (USD Million)
Table 61 France: Clinical Trial Supplies Market, by Therapeutic Area, 2022–2031 (USD Million)
Table 62 France: Clinical Trial Supplies Market, by End User, 2022–2031 (USD Million)
Table 63 U.K.: Clinical Trial Supplies Market, by Clinical Phase, 2022–2031 (USD Million)
Table 64 U.K.: Clinical Trial Supplies Market, by Service, 2022–2031 (USD Million)
Table 65 U.K.: Clinical Trial Supplies Market, by Type, 2022–2031 (USD Million)
Table 66 U.K.: Clinical Trial Supplies Market, by Therapeutic Area, 2022–2031 (USD Million)
Table 67 U.K.: Clinical Trial Supplies Market, by End User, 2022–2031 (USD Million)
Table 68 Spain: Clinical Trial Supplies Market, by Clinical Phase, 2022–2031 (USD Million)
Table 69 Spain: Clinical Trial Supplies Market, by Service, 2022–2031 (USD Million)
Table 70 Spain: Clinical Trial Supplies Market, by Type, 2022–2031 (USD Million)
Table 71 Spain: Clinical Trial Supplies Market, by Therapeutic Area, 2022–2031 (USD Million)
Table 72 Spain: Clinical Trial Supplies Market, by End User, 2022–2031 (USD Million)
Table 73 Italy: Clinical Trial Supplies Market, by Clinical Phase, 2022–2031 (USD Million)
Table 74 Italy: Clinical Trial Supplies Market, by Service, 2022–2031 (USD Million)
Table 75 Italy: Clinical Trial Supplies Market, by Type, 2022–2031 (USD Million)
Table 76 Italy: Clinical Trial Supplies Market, by Therapeutic Area, 2022–2031 (USD Million)
Table 77 Italy: Clinical Trial Supplies Market, by End User, 2022–2031 (USD Million)
Table 78 Rest of Europe: Clinical Trial Supplies Market, by Clinical Phase, 2022–2031 (USD Million)
Table 79 Rest of Europe: Clinical Trial Supplies Market, by Service, 2022–2031 (USD Million)
Table 80 Rest of Europe: Clinical Trial Supplies Market, by Type, 2022–2031 (USD Million)
Table 81 Rest of Europe: Clinical Trial Supplies Market, by Therapeutic Area, 2022–2031 (USD Million)
Table 82 Rest of Europe: Clinical Trial Supplies Market, by End User, 2022–2031 (USD Million)
Table 83 Asia-Pacific: Clinical Trial Supplies Market, by Country/Region, 2022–2031 (USD Million)
Table 84 Asia-Pacific: Clinical Trial Supplies Market, by Clinical Phase, 2022–2031 (USD Million)
Table 85 Asia-Pacific: Clinical Trial Supplies Market, by Service, 2022–2031 (USD Million)
Table 86 Asia-Pacific: Clinical Trial Supplies Market, by Type, 2022–2031 (USD Million)
Table 87 Asia-Pacific: Clinical Trial Supplies Market, by Therapeutic Area, 2022–2031 (USD Million)
Table 88 Asia-Pacific: Clinical Trial Supplies Market, by End User, 2022–2031 (USD Million)
Table 89 China: Clinical Trial Supplies Market, by Clinical Phase, 2022–2031 (USD Million)
Table 90 China: Clinical Trial Supplies Market, by Service, 2022–2031 (USD Million)
Table 91 China: Clinical Trial Supplies Market, by Type, 2022–2031 (USD Million)
Table 92 China: Clinical Trial Supplies Market, by Therapeutic Area, 2022–2031 (USD Million)
Table 93 China: Clinical Trial Supplies Market, by End User, 2022–2031 (USD Million)
Table 94 Japan: Clinical Trial Supplies Market, by Clinical Phase, 2022–2031 (USD Million)
Table 95 Japan: Clinical Trial Supplies Market, by Service, 2022–2031 (USD Million)
Table 96 Japan: Clinical Trial Supplies Market, by Type, 2022–2031 (USD Million)
Table 97 Japan: Clinical Trial Supplies Market, by Therapeutic Area, 2022–2031 (USD Million)
Table 98 Japan: Clinical Trial Supplies Market, by End User, 2022–2031 (USD Million)
Table 99 India: Clinical Trial Supplies Market, by Clinical Phase, 2022–2031 (USD Million)
Table 100 India: Clinical Trial Supplies Market, by Service, 2022–2031 (USD Million)
Table 101 India: Clinical Trial Supplies Market, by Type, 2022–2031 (USD Million)
Table 102 India: Clinical Trial Supplies Market, by Therapeutic Area, 2022–2031 (USD Million)
Table 103 India: Clinical Trial Supplies Market, by End User, 2022–2031 (USD Million)
Table 104 Rest of Asia-Pacific: Clinical Trial Supplies Market, by Clinical Phase, 2022–2031 (USD Million)
Table 105 Rest of Asia-Pacific: Clinical Trial Supplies Market, by Service, 2022–2031 (USD Million)
Table 106 Rest of Asia-Pacific: Clinical Trial Supplies Market, by Type, 2022–2031 (USD Million)
Table 107 Rest of Asia-Pacific: Clinical Trial Supplies Market, by Therapeutic Area, 2022–2031 (USD Million)
Table 108 Rest of Asia-Pacific: Clinical Trial Supplies Market, by End User, 2022–2031 (USD Million)
Table 109 Latin America: Clinical Trial Supplies Market, by Country/Region, 2022–2031 (USD Million)
Table 110 Latin America: Clinical Trial Supplies Market, by Clinical Phase, 2022–2031 (USD Million)
Table 111 Latin America: Clinical Trial Supplies Market, by Service, 2022–2031 (USD Million)
Table 112 Latin America: Clinical Trial Supplies Market, by Type, 2022–2031 (USD Million)
Table 113 Latin America: Clinical Trial Supplies Market, by Therapeutic Area, 2022–2031 (USD Million)
Table 114 Latin America: Clinical Trial Supplies Market, by End User, 2022–2031 (USD Million)
Table 115 Brazil: Clinical Trial Supplies Market, by Clinical Phase, 2022–2031 (USD Million)
Table 116 Brazil: Clinical Trial Supplies Market, by Service, 2022–2031 (USD Million)
Table 117 Brazil: Clinical Trial Supplies Market, by Type, 2022–2031 (USD Million)
Table 118 Brazil: Clinical Trial Supplies Market, by Therapeutic Area, 2022–2031 (USD Million)
Table 119 Brazil: Clinical Trial Supplies Market, by End User, 2022–2031 (USD Million)
Table 120 Mexico: Clinical Trial Supplies Market, by Clinical Phase, 2022–2031 (USD Million)
Table 121 Mexico: Clinical Trial Supplies Market, by Service, 2022–2031 (USD Million)
Table 122 Mexico: Clinical Trial Supplies Market, by Type, 2022–2031 (USD Million)
Table 123 Mexico: Clinical Trial Supplies Market, by Therapeutic Area, 2022–2031 (USD Million)
Table 124 Mexico: Clinical Trial Supplies Market, by End User, 2022–2031 (USD Million)
Table 125 Rest of Latin America: Clinical Trial Supplies Market, by Clinical Phase, 2022–2031 (USD Million)
Table 126 Rest of Latin America: Clinical Trial Supplies Market, by Service, 2022–2031 (USD Million)
Table 127 Rest of Latin America: Clinical Trial Supplies Market, by Type, 2022–2031 (USD Million)
Table 128 Rest of Latin America: Clinical Trial Supplies Market, by Therapeutic Area, 2022–2031 (USD Million)
Table 129 Rest of Latin America: Clinical Trial Supplies Market, by End User, 2022–2031 (USD Million)
Table 130 Middle East & Africa: Clinical Trial Supplies Market, by Clinical Phase, 2022–2031 (USD Million)
Table 131 Middle East & Africa: Clinical Trial Supplies Market, by Service, 2022–2031 (USD Million)
Table 132 Middle East & Africa: Clinical Trial Supplies Market, by Type, 2022–2031 (USD Million)
Table 133 Middle East & Africa: Clinical Trial Supplies Market, by Therapeutic Area, 2022–2031 (USD Million)
Table 134 Middle East & Africa: Clinical Trial Supplies Market, by End User, 2022–2031 (USD Million)
Table 135 Recent Developments, by Company, 2020–2024
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Size Estimation
Figure 7 Global Clinical Trial Supplies Market, by Clinical Phase, 2024 VS. 2031 (USD Million)
Figure 8 Global Clinical Trial Supplies Market, by Service, 2024 VS. 2031 (USD Million)
Figure 9 Global Clinical Trial Supplies Market, by Type, 2024 VS. 2031 (USD Million)
Figure 10 Global Clinical Trial Supplies Market, by Therapeutic Area, 2024 VS. 2031 (USD Million)
Figure 11 Global Clinical Trial Supplies Market, by End User, 2024 VS. 2031 (USD Million)
Figure 12 Clinical Trial Supplies Market, by Geography
Figure 13 Global Clinical Trial Supplies Market, by Clinical Phase, 2024 VS. 2031 (USD Million)
Figure 14 Global Clinical Trial Supplies Market, by Service, 2024 VS. 2031 (USD Million)
Figure 15 Global Clinical Trial Supplies Market, by Type, 2024 VS. 2031 (USD Million)
Figure 16 Global Clinical Trial Supplies Market, by Therapeutic Area, 2024 VS. 2031 (USD Million)
Figure 17 Global Clinical Trial Supplies Market, by End User, 2024 VS. 2031 (USD Million)
Figure 18 Global Clinical Trial Supplies Market, by Geography, 2024 VS. 2031 (USD Million)
Figure 19 North America: Clinical Trial Supplies Market Snapshot
Figure 20 Europe: Clinical Trial Supplies Market Snapshot
Figure 21 Asia-Pacific: Clinical Trial Supplies Market Snapshot
Figure 22 Latin America: Clinical Trial Supplies Market Snapshot
Figure 23 Key Growth Strategies Adopted by Leading Players, 2020–2024
Figure 24 Global Clinical Trial Supplies Market: Competitive Dashboard
Figure 25 Global Clinical Trial Supplies Market: Competitive Benchmarking, by Type
Figure 26 Global Clinical Trial Supplies Market: Market Share Analysis/Market Ranking (2023)
Figure 27 Catalent, Inc.: Financial Snapshot (2023)
Figure 28 Thermo Fisher Scientific Inc.: Financial Snapshot (2023)
Figure 29 Eurofins Scientific SE: Financial Snapshot (2022)
Figure 30 Piramal Pharma Limited: Financial Snapshot (2023)
Figure 31 ICON plc: Financial Snapshot (2023)
Author Name:
Proudly Partnering With Enterprises Around the Globe
Quick Contact
Related Reports
Clinical Trials Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Jun-2024
eClinical Solutions Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Jun-2024
Clinical Lab Automation Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Jan-2024
